Lexicon Pharmaceuticals
LXRX
#6771
Rank
NZ$0.76 B
Marketcap
$2.13
Share price
-2.31%
Change (1 day)
21.59%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2023 (TTM): -$1.11

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.14. In 2022 the company made an earnings per share (EPS) of -$1.02 an increase over its 2021 EPS that were of -$1.02.

EPS history for Lexicon Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.118.88%
2022-$1.02-0%
2021-$1.0210.91%
2020-$0.92-145.08%
2019$2.04-206.09%
2018-$1.93-5.74%
2017-$2.04-10.95%
2016-$2.292640%
2015-$0.08373-96.34%
2014-$2.28-2.53%
2013-$2.34-9.09%
2012-$2.58-37.14%
2011-$4.100%
2010-$4.10-39.66%
2009-$6.803.57%
2008-$6.56-8.2%
2007-$7.15-24.69%
2006-$9.4942.11%
2005-$6.68-22.97%
2004-$8.67-35.09%
2003-$13.36-0%
2002-$13.3662.86%
2001-$8.21-19.54%
2000-$10.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$9.44 729.41%๐Ÿ‡บ๐Ÿ‡ธ USA
$62.56-5,594.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$17.15 1,405.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.30-214.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.69-2,355.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.72 314.71%๐Ÿ‡บ๐Ÿ‡ธ USA
-$44.56 3,813.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.63-330.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.26 10.29%๐Ÿ‡บ๐Ÿ‡ธ USA